ArticleThe Journal of infectious diseases2022

Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI).

Oliver Stirrup et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.